General Antioxidant and Inflammatory Pathways

General Antioxidant and Inflammatory Pathways represent a broad set of signaling networks, including the Nrf2-KEAP1 and NF-κB systems, that regulate cellular responses to oxidative stress and pathogens (Source: PubMed, PMID: 30005331). The antioxidant response is largely governed by the transcription factor Nrf2, which binds to Antioxidant Response Elements (ARE) to trigger the synthesis of detoxifying enzymes (Source: NIH, PMC4290634). Conversely, inflammatory pathways are often mediated by NF-κB, which promotes the transcription of pro-inflammatory cytokines such as TNF-alpha and IL-1 beta (Source: StatPearls, Inflammation). Dysregulation of these interconnected pathways is a primary driver in the progression of chronic diseases like rheumatoid arthritis, neurodegeneration, and cardiovascular disorders (Source: Nature Reviews Drug Discovery). Drugs targeting these pathways include Nrf2 activators, such as dimethyl fumarate, and various anti-inflammatory agents like TNF inhibitors (Source: PubChem). Because these pathways are essential for normal cellular function and host defense, therapeutic targeting requires careful calibration to avoid adverse effects such as immunosuppression or the disruption of essential redox signaling (Source: PMC, PMC4290634). Overall, while these pathways offer numerous points for therapeutic intervention, they are considered a category of biological processes rather than a single discrete drug target.

Other names

Oxidative stress signalingInflammatory signaling cascadesRedox-inflammatory axisAntioxidant response element (ARE) signaling

Modulation of redox-sensitive transcription factors and inhibition of pro-inflammatory signaling mediators.